EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males

Marwan Kameran Qader Salihi, Noor-Aldeen Jamal Hasan Al-Ansare, Azma Abdul Malek

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 03.11.2026 · 11 (2) · 245-250

DOI: 10.54133/ajms.v11i2.3376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 03.11.2026. Verfasst von Marwan Kameran Qader Salihi und 2 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgenetic alopecia is hair loss in men. Minoxidil is an established treatment, whereas botulinum toxin is an uncertain therapeutic option.

Objective

To compare the therapeutic efficacy of minoxidil and BOTOX®.

Methods

Our randomized, comparative interventional clinical study included male patients with androgenetic alopecia who were randomly allocated to two treatment groups. Group I received topical 5% minoxidil twice daily, while Group II received botulinum toxin type A. Treatment response was assessed next month using vertex hair density and patient-reported hair-growth improvement.

Results

The clinical and demographic characteristics were comparable in our two groups at baseline. Vertex hair density is comparable at baseline (84.5 vs. 78.5 hairs/cm², p=0.1), at 3 months (84.5 vs. 81 hairs/cm², p=0.3), and at 6 months (90 vs. 86 hairs/cm², p=0.2) in the minoxidil and BOTOX® groups, respectively. Within-group analysis demonstrated a statistically significant increase in hair density over time in the minoxidil group (p=0.007), with no significant change observed in the BOTOX® group (p=0.6). However, the change in hair density and improvement were not very different in our two study groups (p=0.7 and p=0.5, respectively). At month 6, hair growth was significantly favored by minoxidil (p=0.001), with 86.7% reporting some degree of improvement compared with 73.4% in the BOTOX® group.

Conclusions

Topical 5% minoxidil produced a significant improvement in vertex hair density and was associated with greater patient-reported improvement over six months. Botulinum toxin showed less effect.

Zitieren

APA

Salihi, M. K. Q., Al-Ansare, N. J. H., & Malek, A. A. (2026). Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 11(2), 245-250. https://doi.org/10.54133/ajms.v11i2.3376

Vancouver

Salihi MKQ, Al-Ansare NJH, Malek AA. Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;11(2):245-250. doi:10.54133/ajms.v11i2.3376

BibTeX
@article{Salihi2026,
  author = {Salihi, Marwan Kameran Qader and Al-Ansare, Noor-Aldeen Jamal Hasan and Malek, Azma Abdul},
  title = {Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males},
  journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {245--250},
  doi = {10.54133/ajms.v11i2.3376}
}
Kostenlos starten →